SOD1 and inflammatory bowel disease: It was shown previously that recombinant lactobacilli engineered to secrete SOD can ameliorate intestinal inflammation in mouse models of inflammatory bowel disease (Carroll et al., 2007; Watterlot et al., 2010; Hou et al., 2014).